Cargando…

Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that persists lifelong in the host. In ∼4% of infected people, HTLV-1 causes a chronic disabling neuroinflammatory disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The pathogenesis of HAM/TSP is unknown a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tattermusch, Sonja, Skinner, Jason A., Chaussabel, Damien, Banchereau, Jacques, Berry, Matthew P., McNab, Finlay W., O'Garra, Anne, Taylor, Graham P., Bangham, Charles R. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266939/ https://www.ncbi.nlm.nih.gov/pubmed/22291590 http://dx.doi.org/10.1371/journal.ppat.1002480

Ejemplares similares

An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection
por: Tattermusch, Sonja, et al.
Publicado: (2011)

Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling
por: Pitt, Jonathan M., et al.
Publicado: (2016)

An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis
por: Berry, Matthew P. R., et al.
Publicado: (2010)

Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis
por: McNab, Finlay W, et al.
Publicado: (2011)

Progression of whole blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in patients with severe influenza
por: Dunning, Jake, et al.
Publicado: (2018)

The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis
por: Blankley, Simon, et al.
Publicado: (2016)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul, et al.
Publicado: (2011)

Identification of the Key Differential Transcriptional Responses of Human Whole Blood Following TLR2 or TLR4 Ligation In-Vitro
por: Blankley, Simon, et al.
Publicado: (2014)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul DW, et al.
Publicado: (2011)

Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency
por: Park, Joon, et al.
Publicado: (2013)

Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway
por: Redford, Paul S., et al.
Publicado: (2014)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
por: Martin, Fabiola, et al.
Publicado: (2014)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Taylor, Graham P.
Publicado: (2015)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Macchi, Beatrice, et al.
Publicado: (2011)

Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
por: Martin, Fabiola, et al.
Publicado: (2012)

Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis
por: Pankla, Rungnapa, et al.
Publicado: (2009)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy
por: Buell, Kevin G., et al.
Publicado: (2016)

Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy
por: Bloom, Chloe I., et al.
Publicado: (2012)

Assessing the human immune system through blood transcriptomics
por: Chaussabel, Damien, et al.
Publicado: (2010)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

High frequency of CD4(+)FoxP3(+) cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL response
por: Toulza, Frederic, et al.
Publicado: (2008)

Type I IFN Induces IL-10 Production in an IL-27–Independent Manner and Blocks Responsiveness to IFN-γ for Production of IL-12 and Bacterial Killing in Mycobacterium tuberculosis–Infected Macrophages
por: McNab, Finlay W., et al.
Publicado: (2014)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Clonality of HTLV-1 differs between infected CD8+ T cells and infected CD4+ T cells in vivo
por: Melamed, Anat, et al.
Publicado: (2014)

Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers
por: Harding, Daniel, et al.
Publicado: (2022)

Neurofilament Light in CSF and Plasma Is a Marker of Neuronal Damage in HTLV-1–Associated Myelopathy and Correlates With Neuroinflammation
por: Rosadas, Carolina, et al.
Publicado: (2021)

Susceptibility of HBZ and Tax expressing primary HTLV-1+ T cell clones to CTL lysis
por: Rowan, Aileen G, et al.
Publicado: (2011)

Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test
por: Adonis, Adine, et al.
Publicado: (2016)

Using the 6 minute walk to investigate endurance in patients with HTLV associated myelopathy
por: Adonis, A, et al.
Publicado: (2014)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Clonality of HTLV-2 in natural infection
por: Melamed, Anat, et al.
Publicado: (2014)

Tumor suppressor in lung cancer identifies latency infected cells in non malignant HTLV-1 infection
por: Manivannan, Kiruthika, et al.
Publicado: (2015)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT
por: Viana, Graça Maria de Castro, et al.
Publicado: (2014)

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003)

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
por: Bloom, Chloe I., et al.
Publicado: (2013)

Correction: Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
por: Bloom, Chloe I., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_163vi2ralcsq18kk0a41pondd0